Atlas Trials

Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism

Clinical trial NCT00338598 · COMPLETED

Trial details

NCT number
NCT00338598
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
AlcoholismSchizophrenia
Start date
2003-06-01
Primary completion
2015-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.